Sirinian Maria Isabella, Belleudi Francesca, Campagna Filomena, Ceridono Mara, Garofalo Tina, Quagliarini Fabiana, Verna Roberto, Calandra Sebastiano, Bertolini Stefano, Sorice Maurizio, Torrisi Maria Rosaria, Arca Marcello
Department of Clinical and Applied Medical Therapy, University of Rome La Sapienza, Italy.
J Biol Chem. 2005 Nov 18;280(46):38416-23. doi: 10.1074/jbc.M504343200. Epub 2005 Aug 29.
ARH is a newly discovered adaptor protein required for the efficient activity of low density lipoprotein receptor (LDLR) in selected tissues. Individuals lacking ARH have severe hypercholesterolemia due to an impaired hepatic clearance of LDL. It has been demonstrated that ARH is required for the efficient internalization of the LDL-LDLR complex and to stabilize the association of the receptor with LDL in Epstein-Barr virus-immortalized B lymphocytes. However, little information is available on the role of ARH in liver cells. Here we provide evidence that ARH is codistributed with LDLR on the basolateral area in confluent HepG2-polarized cells. This distribution is not modified by the overexpression of LDLR. Conversely, the activation of the LDLR-mediated endocytosis, but not the binding of LDL to LDLR, promotes a significant colocalization of ARH with LDL-LDLR complex that peaked at 2 min at 37 degrees C. To further assess the role of ARH in LDL-LDLR complex internalization, we depleted ARH protein using the RNA interference technique. Twenty-four hours after transfection with ARH-specific RNA interference, ARH protein was depleted in HepG2 cells by more than 70%. Quantitative immunofluorescence analysis revealed that the depletion of ARH caused about 80% reduction in LDL internalization. Moreover, our findings indicate that ARH is associated with other proteins of the endocytic machinery. We suggest that ARH is an endocytic sorting adaptor that actively participates in the internalization of the LDL-LDLR complex, possibly enhancing the efficiency of its packaging into the endocytic vesicles.
ARH是一种新发现的衔接蛋白,在特定组织中低密度脂蛋白受体(LDLR)的有效活性中发挥作用。缺乏ARH的个体由于肝脏对LDL的清除受损而患有严重的高胆固醇血症。研究表明,在爱泼斯坦-巴尔病毒永生化的B淋巴细胞中,ARH是LDL-LDLR复合物有效内化所必需的,并且能稳定受体与LDL的结合。然而,关于ARH在肝细胞中的作用,目前所知甚少。在此,我们提供证据表明,在汇合的极化HepG2细胞中,ARH与LDLR在基底外侧区域共分布。这种分布不会因LDLR的过表达而改变。相反,LDLR介导的内吞作用的激活,而非LDL与LDLR的结合,会促进ARH与LDL-LDLR复合物的显著共定位,在37℃下2分钟时达到峰值。为了进一步评估ARH在LDL-LDLR复合物体内化中的作用,我们使用RNA干扰技术耗尽了ARH蛋白。用ARH特异性RNA干扰转染24小时后,HepG2细胞中的ARH蛋白减少了70%以上。定量免疫荧光分析显示,ARH的耗尽导致LDL内化减少约80%。此外,我们的研究结果表明,ARH与内吞机制的其他蛋白质相关。我们认为,ARH是一种内吞分选衔接蛋白,积极参与LDL-LDLR复合物的内化过程,可能会提高其包装到内吞小泡中的效率。